Role of liver biopsy in management of liver diseases without hepatic nodules following end of the interferon era: experience of a tertiary referral center

Clinical and Experimental Medicine · Published 2025-01-01 · Journal article · DOI 10.1007/s10238-022-00797-1

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s10238-022-00797-1

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Increased Gal-3BP plasma levels in hospitalized patients infected with SARS-CoV-2 · Clinical and Experimental Medicine · 2022 · Same journal
• Immunohistochemical evaluation and prognostic value of monocarboxylate transporter 1 (MCT1) and 4 (MCT4) in T-cell non-Hodgkin lymphoma · Clinical and Experimental Medicine · 2025 · Same journal
• Influence of AFP on surgical outcomes in non-B non-C patients with curative resection for hepatocellular carcinoma · Clinical and Experimental Medicine · 2025 · Same journal
• High levels of HPV16-L1 antibody but not HPV16 DNA load or integration predict oropharyngeal patient outcome: The Papillophar study · Clinical and Experimental Medicine · 2022 · Same journal
• Inhibitory KIR2DL2 receptor and HHV-8 in classic or endemic Kaposi sarcoma · Clinical and Experimental Medicine · 2022 · Same journal
• A study of the prognostic value of long non-coding RNA CASC15 in human solid tumors utilizing The Cancer Genome Atlas (TCGA) datasets and a meta-analysis · Clinical and Experimental Medicine · 2022 · Same journal
• Detection of hepatitis C virus (HCV) RNA in the peripheral blood mononuclear cells of HCV-infected patients following sustained virologic response · Clinical and Experimental Medicine · 2022 · Same journal
• Correction to: Evaluation of admission levels of P, E and L selectins as predictors for thrombosis in hospitalized COVID-19 patients · Clinical and Experimental Medicine · 2022 · Same journal